Review Article

Pharmacological Strategies to Prevent Contrast-Induced Acute Kidney Injury

Table 5

Prospective, randomized clinical trials comparing efficacy of vitamin C with placebo and other agents for contrast-induced AKI after angiography prophylaxis.

AuthorsYearType of procedure and contrast mediaNumber of patients
Intervention versus control
Study protocolIntravascular volume expansion and NAC protocolCI-AKI definitionMean GFR
Intervention versus control (mL/min/1.73 m2)
Incidence of CI-AKIRRT requirement
Intervention versus control (%)
InterventionControlIntervention versus control (%) value

Spargias et al. [88]2004CAG
LONICM or
IONICM
118 versus 113Ascorbic acid 3 g po 2 hours before and 2 g in the night and in the morning afterPlaceboNSS 50–125 mL/h from randomization to 6 hours after↑Cr ≥25%/2 days or
↑Cr ≥0.5/2 days
61.1 versus 68.19 versus 200.02ND

Boscheri et al. [89]2007CAG
ND
74 versus 69Ascorbic acid 1 gPlaceboNSS before and afterNDND6.8 versus 4.3NSND

Jo et al. [90]2009CAG
Iodixanol
106 versus 106Ascorbic acid po q12h 3 and 2 g before and 2 and 2 g afterNAC 1200 mg po bid 4 doses, begin 1st dose in the evening beforeN/2 1 mL/kg/h 12 hours before and after↑Cr ≥25%/2 days or
↑Cr ≥0.5/2 days
53.7 versus 53.74.4 versus 1.20.3702 versus 1

Zhou and chen [91]2012CAG
Unspecified
74 versus 82Ascorbic acid 3 g IV before and 0.5 g po q12h for 2 days afterPlaceboNSS 1 mL/kg/h 4 hours before and 12 hours after↑Cr ≥25%/2 days or
↑Cr ≥0.5/2 days
52.5 versus 53.26.3 versus 5.40.69ND

Brueck et al. [92]2013CAG
Iopromide
104 versus 208 versus 208Ascorbic acid 500 mg IV at 24 hours and 1 hour before(1) NAC 600 mg iv at 24 hours and 1 hour before
(2) Placebo
NSS 1 mL/kg/h 12 hours before and 12 hours after↑Cr ≥0.5/3 days43.0 versus 40.2 versus 42.024.5 versus 27.6 versus 32.10.11* 
0.20**
0 versus 0 versus 0

value of *ascorbic acid and **NAC compared to placebo group.
bid: twice daily; CAG: coronary angiography; CI-AKI: contrast-induced acute kidney injury; Cr: creatinine; g: gram; h: hour; IONICM: isoosmolarity nonionic contrast media; IV: intravenous; kg: kilogram body weight; LONICM: low osmolarity nonionic contrast media; kg: kilogram body weight; mg: milligram; mL: milliliter; NAC: N-acetylcysteine; ND: no data; NSS: normal saline solution; N/2: 0.45% NaCl; po: per oral route; q12h: every 12 hours; RRT: renal replacement therapy.